publication venue for
- Multidisciplinary Real-World Experience With Bilastine, a Second Generation Antihistamine. 19:145-154. 2020
- Cohort Using a Ceramides Containing Cleanser and Cream With Salicylic Acid for Dry, Flaking, and Scaling Skin Conditions.. 18:80-85. 2019
- Transitioning Between Brodalumab and Secukinumab in Moderate to Severe Psoriasis: An Early Look.. 15:941-943. 2016
- Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.. 13:1380-1386. 2014
- Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.. 12:1122-1129. 2013
- An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.. 10:396-402. 2011
- Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies.. 9:639-646. 2010
- Biologic survival.. 8:329-333. 2009
- Treatment of severe facial psoriasis with adalimumab.. 7:1165-1167. 2008
- Prevalence and severity of facial and truncal acne in a referral cohort. 7:553-556. 2008
- Prevalence and severity of facial and truncal acne in a referral cohort.. 7:551-556. 2008
- Innovative uses of imiquimod.. 4:58-63. 2005